openPR Logo
Press release

Insights into Janus Kinase (JAK) Inhibitors Market: Global Trends and Analysis

04-25-2024 05:52 AM CET | Chemicals & Materials

Press release from: The Business research company

Janus Kinase (JAK) Inhibitors

Janus Kinase (JAK) Inhibitors

The janus kinase (jak) inhibitors market size has grown rapidly in recent years. It will grow from $17.29 billion in 2023 to $20.41 billion in 2024 at a compound annual growth rate (CAGR) of 18.1%. The growth in the historic period can be attributed to recognition of the role of jak-stat signaling pathway in diseases, increased prevalence of autoimmune disorders, unmet medical needs in rheumatology and dermatology, development of targeted therapies for inflammatory conditions, improvement in diagnostic capabilities for autoimmune diseases.

The janus kinase (jak) inhibitors market size is expected to see rapid growth in the next few years. It will grow to $39.92 billion in 2028 at a compound annual growth rate (CAGR) of 18.3%. The growth in the forecast period can be attributed to growth of biopharmaceutical research and development, regulatory approvals for jak inhibitors in specific indications, expansion of clinical trials for jak inhibitor drugs, advances in personalized and precision medicine, adoption of jak inhibitors in combination therapies, integration of digital health technologies in autoimmune care. Major trends in the forecast period include focus on developing novel selective jak inhibitors for improved safety profiles, development of jak inhibitors with extended-release formulations, integration of artificial intelligence in jak inhibitor drug discovery, exploration of jak inhibitors in novel drug delivery systems, collaboration between pharmaceutical companies and research institutions.

Market Overview -
Janus Kinase (JAK) inhibitors are a class of drugs that block the activity of Janus Kinase enzymes. Janus Kinase (JAK) inhibitors are used for chronic inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, axial spondylarthritis, ulcerative colitis, atopic dermatitis, and alopecia areata.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12524&type=smp

Surging Instances Of Autoimmune Diseases Propel The Janus Kinase (JAK) Inhibitors Market
The increase in instances of autoimmune diseases is expected to propel the growth of the Janus kinase (JAK) inhibitors market. Autoimmune diseases are a broad group of disorders characterized by an abnormal immune response in which the immune system mistakenly attacks and damages healthy cells, tissues, and organs. Janus Kinase (JAK) inhibitors provide therapeutic benefits for autoimmune diseases by modulating the immune system, reducing inflammation, and alleviating symptoms such as rheumatoid arthritis. For instance, in December 2022, according to the National Psoriasis Foundation, a US-based non-profit organization serving people with Psoriasis and psoriatic arthritis, Psoriasis affected more than 8 million people in America and 125 million individuals worldwide, or 2 to 3% of the population. Furthermore, in September 2022, according to the Centers for Disease Control and Prevention, a US-based national public health agency, Diabetes was diagnosed in 28.7 million people of all ages, or 8.7% of the US population, and 5.7% of all US individuals with confirmed Diabetes-or 1.6 million people aged 20 and older-reported having type 1 diabetes and requiring insulin. Therefore, the increase in instances of autoimmune diseases is driving the growth of the Janus kinase (JAK) inhibitors market.

Competitive Landscape -
Major companies operating in the janus kinase (jak) inhibitors market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., GSK Plc., Takeda Pharmaceutical Company Ltd., Eli Lilly and Co., Gilead Sciences Inc., Boehringer Ingelheim Group, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., AstraZeneca PLC, Mitsubishi Tanabe Pharma Corporation, Incyte Corporation, Kyowa Hakko Kirin Co. Ltd., Galapagos NV, Sierra Oncology Inc., Dizal Pharmaceutical, Reistone Biopharma Co. Ltd., CTI BioPharma Corp., Celon Pharma SA, Theravance Biopharma Inc., Aclaris Therapeutics Inc., Alexion Pharmaceuticals Inc.

Technological Breakthroughs Drive Product Innovation In The Janus Kinase (JAK) Inhibitors Market
Product innovation is a key trend gaining popularity in the Janus kinase (JAK) inhibitors market. Major companies operating in the Janus kinase (JAK) inhibitors market are focused on innovating technologically advanced solutions to sustain their position in the market. For instance, in May 2022, Eli Lilly and Company, a US-based pharmaceutical company, and Incyte, a Switzerland-based biopharmaceutical company, announced the approval of OLUMIANT (baricitinib) by the U.S. Food and Drug Administration (FDA). It is the first and only JAK inhibitor FDA-approved for treating COVID-19 in some hospitalized individuals who need varying levels of oxygen assistance. OLUMIANT is approved for treating adult hospital patients with extracorporeal membrane oxygenation (ECMO), non-invasive or invasive mechanical breathing, or COVID-19 disease 2019 (COVID-19).

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/janus-kinase-jak-inhibitors-global-market-report

Key Segments -

The janus kinase (jak) inhibitors market covered in this report is segmented -

1) By Inhibitors Type: Ruxolitinib, Tofacitinib, Oclacitinib, Baricitinib, Peficitinib, Other Inhibitor Types
2) By Mode Of Administration: Injectable, Oral, Other Modes Of Administration
3) By Distribution Channel: Hospital pharmacies, Retail pharmacies, Online pharmacies
4) By Application: Autoimmune Disorders, Oncology, Inflammatory Disorders, Metabolic Disorders

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insights into Janus Kinase (JAK) Inhibitors Market: Global Trends and Analysis here

News-ID: 3475596 • Views:

More Releases from The Business research company

Evolving Market Trends In The Integrated Geophysical Services Industry: Enhancing Geophysical Surveys With Drones For Efficiency In Harsh Environments
Evolving Market Trends In The Integrated Geophysical Services Industry: Enhancin …
The Integrated Geophysical Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Integrated Geophysical Services Market Size During the Forecast Period? The integrated geophysical services market has experienced consistent growth in recent years, expected to rise from $2.35 billion in 2024 to
Global HR Advisory Services Market: Key Trends, Market Share, Growth Drivers, And Forecast For 2025-2034
Global HR Advisory Services Market: Key Trends, Market Share, Growth Drivers, An …
The HR advisory services market report describes and explains the HR advisory services market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region. The global HR advisory services market reached a value of nearly $155.74 billion in 2024, having grown at a compound annual growth rate (CAGR) of 4.22% since
High Voltage Aluminium Electrolytic Capacitors Global Market Report 2025: Size, Trends, and Growth Insights for Global Expansion
High Voltage Aluminium Electrolytic Capacitors Global Market Report 2025: Size, …
The high voltage aluminum electrolytic capacitors report describes and explains the high voltage aluminum electrolytic capacitors market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region. The global high voltage aluminum electrolytic capacitors market reached a value of nearly $4.10301 billion in 2024, having grown at a compound annual growth
Global Vertical Market Software Market: Key Trends, Market Share, Growth Drivers, and Forecast for 2025-2034
Global Vertical Market Software Market: Key Trends, Market Share, Growth Drivers …
The vertical market software report describes and explains the vertical market software market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region. The global vertical market software market reached a value of nearly $152.61027 billion in 2024, having grown at a compound annual growth rate (CAGR) of 12.11% since 2019.

All 5 Releases


More Releases for Janus

Key Trends Influencing the Growth of the Janus Kinase (JAK) Inhibitors Market in …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Janus Kinase (JAK) Inhibitors Market Through 2025? The market size of Janus Kinase (JAK) inhibitors has experienced a quick growth over the recent years. The market, which stood at $20.19 billion in 2024, is projected to see a rise to $23.56 billion
Leading Growth Driver in the Janus Kinase (JAK) Inhibitors Market in 2025: Surgi …
Which drivers are expected to have the greatest impact on the over the janus kinase (jak) inhibitors market's growth? The escalating occurrences of autoimmune disorders are anticipated to stimulate the expansion of the Janus kinase (JAK) inhibitors market. These disorders involve a broad spectrum of abnormalities within the immune system where it erroneously attacks and destroys healthy cells, tissues, and organs. The therapeutic benefits of Janus Kinase (JAK) inhibitors for autoimmune
Janus Kinase (JAK) Inhibitor Pipeline Therapeutics Assessment Report 2024 (Updat …
DelveInsight's, "Janus Kinase Inhibitor Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Janus Kinase (JAK) Inhibitor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Janus Kinase
Janus Kinase (JAK) Inhibitors Market Competitor Analysis, Growth, Insights, Tren …
"The Business Research Company recently released a comprehensive report on the Global Janus Kinase (JAK) Inhibitors Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free
Janus kinase (JAK) Inhibitors Competitive Landscape Report 2024
DelveInsight's, "Janus kinase inhibitors Competitive landscape 2024" report provides comprehensive insights about 40+ Janus kinase Inhibitors Companies and 45+ drugs in Janus kinase inhibitors Competitive landscape. It covers the Janus kinase Inhibitors therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Janus kinase Inhibitors Report • DelveInsight's Janus kinase Inhibitors report depicts a robust space
Janus Kinase (JAK) Inhibitors Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Janus Kinase (JAK) Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Janus Kinase (JAK) Inhibitors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Janus Kinase (JAK)